Search
Granulomatosis With Polyangiitis
go.drugbank.com/conditions/DBCOND0035157Synonyms: Wegener's granulomatosis without renal involvementCrohn's Disease (CD)
go.drugbank.com/conditions/DBCOND0052193Drugs: Azathioprine · Budesonide · Darvadstrocel · Hydrocortisone · Mercaptopurine · Methotrexate +3 moreSynonyms: Crohn's disease, unspecified, without complicationsSeizure Disorders
go.drugbank.com/conditions/DBCOND0046733Synonyms: Epilepsy, unspecified, not intractable, without status epilepticusVascular Dementia (VaD)
go.drugbank.com/conditions/DBCOND0132452Drugs: DonepezilSynonyms: Vascular dementia, unspecified severity, without behavioral disturbance, psychotic disturbance, mood disturbance, and anxietyAtherosclerosis of Coronary Artery
go.drugbank.com/conditions/DBCOND0047248Synonyms: Atherosclerotic heart disease of native coronary artery without angina pectorisNedosiran
go.drugbank.com/drugs/DB17635ApprovedInvestigational[A261685] Nedosiran was approved by the FDA on October 2<sup>nd</sup>, 2023, under the brand name RIVFLOZA to lower urinary oxalate levels in children 9 years of age and older and adults with primary
Pegzilarginase
go.drugbank.com/drugs/DB14780ApprovedFDA in February 2026 for the treatment of hyperargininemia in adult and pediatric patients aged 2 years and older with ARG1-D, to be used in conjunction with dietary protein restriction. … [L56053] By substituting the native manganese cofactor with cobalt to enhance catalytic activity, this agent effectively degrades elevated plasma arginine into ornithine and urea, thereby mitigating the
Hydroquinone
go.drugbank.com/drugs/DB09526ApprovedInvestigationalIt can be used alone, but is more frequently found in combination with other agents such as alpha-hydroxy acids, corticosteroids, retinoids, or sunscreen.
Products: SLMD Skincare by Sandra Lee, M.D. - Dark Spot FixElasomeran
go.drugbank.com/drugs/DB15654ApprovedInvestigationalIn clinical trials, there were no differences in the safety profiles between younger and older (65 years of age and older) study participants. … [L39160, L39277] A similar booster dose is also available in the US for patients 18 years of age and older.
Ozenoxacin
go.drugbank.com/drugs/DB12924Approvedand older. … s Xepi (ozenoxacin 1%) as a topically applied cream indicated for the treatment of impetigo caused by *Staphylococccus aureus* or *Streptococcus pyogenes* in adult and pediatric patients 2 months of age